NCT06225830Completed
Unlocking Movement Potential: Enhancing Parkinson's Disease Treatment With Robotic EksoSkeleton
Utilization of Robotic EksoSkeleton to Achieve High Dosing, Intensity, and Complexity of Gait in Treatment of People With Parkinson's Disease
Source: ClinicalTrials.gov · Last updated 30 Sept 2026
Brief summary (registry, in English)
The goal of this study is to see how well therapy with the Eksobionic Exoskeleton (Esko) works for people with Parkinson's disease (PWPD). Esko is a robotic device that provides high repetition and intensity training. The investigators will examine its impact on walking, balance, and quality of life before, during and after an eight-week intervention program. The results will lay the groundwork for future trials, potentially leading to long-term improvements in mobility and quality of life for PWPD.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 13 (actual)
- First submitted
- 18 Dec 2023
- Start date
- 4 Jun 2024
- Primary completion date
- 24 Aug 2026
- Lead sponsor
- Albert Einstein Healthcare Network
- Diseases
- Parkinson disease
- NCT number
- NCT06225830
What you commit to
- Study type: Interventional
- Participants enrolled: 13
- From 4 Jun 2024 to the primary completion date, 24 Aug 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Currently involved in another intervention study or physical therapy course of care
- Concurrent neurological disease
- Unable to sustain current medication regimen. Participant reports change in Parkinson's Medication in the past week.
Other illness
- Unresolved deep vein thrombosis
- History of long bone fractures secondary to osteoporosis
Other
- Leg length discrepancy, self-reported.
- Spinal instability
- Severe muscular or skeletal pain
- Open skin ulcerations on buttocks or other body surfaces in contact with exoskeleton or harness
- Pregnancy
- Cognitive impairments - unable to follow 2 steps commands and communicate for pain or to stop session
- Participant requires the assistance of more than one therapist to transfer safely.
- Uncontrolled or severe orthostatic hypotension that limits standing tolerance; defined as sustained, symptomatic drops in systolic and diastolic blood pressure when moving from sitting to standing
- Active heterotrophic ossification (HO), hip dysplasia or hip/knee axis abnormalities
- Colostomy
- Any reason the therapist may deem as harmful to the participant to enroll or continue in the study
Who the study is looking for
- Physician diagnosed idiopathic Parkinson's disease
- All Hoehn and Yahr (H\&Y) stages will be eligible for inclusion in the study
- Able to consent to participation in the research study
- Pt agreeable to participate in 45-60 minutes of high intensity (RPE 14-17 for 30 minutes) gait training/ physical therapy.
- Sufficient upper extremity strength to use a front wheeled walker
- Pt to have self- reported walking/balance deficits
- Age: Over age 18
- Must be able to tolerate at least 15 min upright
- Weigh 220 pounds (100kg) or less
- Approximately between 5'0" and 6'4" tall
- Have near normal range of motion in hips, knees, and ankles "Can you stand up and straighten your knees even for just a second?" or "Can you lay flat and straighten your knees so there is no bend in the knee?"
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Jefferson Moss-Magee Rehabilitation - Elkins Park Coordinator of this site? Confirm its status | Elkins Park | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.